T2DM is characterised by a decrease in insulin secretion by pancreatic β-cells (Huang et al., 2022) and the development of insulin resistance in the target tissues, including the liver, muscle and adipose tissues, which ultimately leads to hyperglycaemia (Liu et al., 2022). This evidence concerns the gene INS and type 2 diabetes mellitus.